Why have we not yet developed a simple blood test for TBI?
نویسندگان
چکیده
منابع مشابه
A treatment for oral precancerous lesions: why do we not yet have a treatment?
One thought kept coming back as I was preparing this presentation: “How is it possible that despite our having an early marker for oral cancer namely, oral dysplasias we are no more effective today than we were 50 years ago in the fight against oral cancer? By this I mean that the mortality rates for oral cancer have not changed in spite of the professional awareness of precancerous lesions, an...
متن کاملWhy Should We Have a Periodic Safety and Performance Program for Medical Devices
Nowadays, more than 10,000 different types of medical devices can be found in hospitals.These devices used in medical centers and hospitals for monitoring and treatment of patients require periodic safety and performance checking in order to have confidence in their functioning and operation. Physicians need better accurate medical measurements in order to better diagnose diseases, monitor pati...
متن کاملWhy do we not yet have a human immunodeficiency virus vaccine?
A 2-day meeting to explore why we do not yet have a human immunodeficiency virus (HIV) vaccine was held under the joint sponsorship of the Simons Center for Systems Biology at the Institute for Advanced Study and the International AIDS Vaccine Initiative, with additional support from Merck & Co., at the Institute for Advanced Study in Princeton, NJ, on 29 and 30 May 2008. The meeting brought to...
متن کاملWhy don’t we have an effective tuberculosis vaccine yet?
Mycobacterium tuberculosis (M.tb) has co-evolved with humans for thousands of years, to cause tuberculosis (TB). The success of M.tb as a pathogen is in part because of the ways in which M.tb evades and exploits different cell subsets, to persist and cause disease. M.tb expresses numerous molecules to prevent its recognition and destruction by immune cells. The only licensed vaccine against TB,...
متن کاملWhy do we not have a cure for rheumatoid arthritis?
There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Neurotherapeutics
سال: 2015
ISSN: 1473-7175,1744-8360
DOI: 10.1586/14737175.2015.1031112